期刊文献+

超声成像技术分析糜酶转基因小鼠心脏功能

Analysis the Heart Function of Human Chymase Gene Transgenic Mouse with Echocardiography
下载PDF
导出
摘要 目的应用小动物高频超声技术对糜酶转基因小鼠的心功能进行分析,以探索糜酶基因对心脏结构和功能的影响。方法通过VisualSonics Vevo770高分辨率小动物超声系统检测不同年龄的转基因小鼠及对照小鼠包括心壁厚度、主动脉血流速度、左心室内径、左心室容积、每搏输出量、射血分数、短轴缩短率和心输出量等的心脏功能指标的改变进行比较分析。结果随着小鼠年龄的增大,转基因阳性小鼠心壁厚度和主动脉血流速度逐渐增加,至6月龄时,转基因小鼠的左心室前壁收缩期厚度增加37%,增长率是对照小鼠的1.2倍(P<0.05);主动脉血流速度比对照小鼠高29%(P<0.05);转基因阳性小鼠的左心室内径、左心室容积、每搏输出量、射血分数、短轴缩短率和心输出量等的心脏功能指标表现出和以上变化相一致的表型。结论转基因小鼠糜酶表达水平升高,引起心脏AngⅡ形成增多,可使心肌细胞的收缩力提高;心肌细胞肥大,心壁增厚;且有随年龄增加的趋势,可研究建立慢性、老年性肥厚型心脏病模型。 Objective To analyze the function of human Chymase gene in heart in the transgenic mouse. Methods The heart function of the transgenic mice and the wild type mice were analyzed by echocardiography with Vevo770 at different ages, including LVAW, LVPW, aortic velocity, Diameter, Volume, Stroke volume, Ejection fraction, Fractional shortening, Cardiac output. Results The heart function of the transgenic mice and the wild type mice were analyzed at 1 month old, 2 months old, 4 months old and 6 months old. The LVAW of transgenic heart was increased up to 37 % and the increasing rate of the transgenic heart was 1.2 fold of the control heart (P 〈 0.05) at 6 months old. The aortic velocity of transgenic mice was increased at 4 months old compared with the wild type mice ( P 〈 0.05), and the increasing was 29% higher than the control mice ( P 〈 0.05). The function of the transgenic hear on Diameter, Volume, Stroke volume, Ejection fraction Fractional shortening and Cardiac output was also changed corresponding with the increasing of LVAW and aortic velocity. Conclusion Our results suggested that the expression of human Chymase gene in heart tissue of mouse caused the increasing of Ang Ⅱ and resulted in the hypertrophy of myocardiocytes, the increasing of LVAW and LVPW with aging. This transgenic mouse could be used as a hypertrophic cardiomyopathy model.
出处 《中国比较医学杂志》 CAS 2007年第11期633-636,共4页 Chinese Journal of Comparative Medicine
基金 北京市转基因平台建设项目TC2006-02(Z0006303041231) 中央级公益性科研院所基本科研业务费专项基金(DW200704)
关键词 糜酶 转基因 小鼠 心脏超声 Chymase Transgene Mouse Echocardiography
  • 相关文献

参考文献10

二级参考文献36

  • 1何泉,陈兰英.糜酶的研究进展[J].生理科学进展,1996,27(2):129-133. 被引量:3
  • 2[1]Okunishi H,Oka Y,Shiota N,et al. Marked species-difference in the vascular angiotensin II-forming pathways:humans versus rodents[J]. Jpn J Pharmacol,1993,62:207-210.
  • 3[2]McConnaughey MM,McConnaughey JS,Ingenito AJ. Practical considerations of the pharmacology of angiotensin receptor blockers[J]. J Clin Pharmacol, 1999,39(6):547-559.
  • 4[3]Urata H,Kinoshita A,Misono KS et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart[J]. J Biol Chem, 1990,256(36):22348-22357.
  • 5[4]Hikaru N,Sigrid H,Ovidiu B,et al. AngiotensinⅠconverting enzyme and chymase in cardiovascular tissues[J]. Kidney International,1996,49(suppl 55):S18-S23.
  • 6[5]Hollenberg NK. Implications of species difference for clinical investigation:studies on the renin-angiotensin system[J]. Hypertension,2000,35(part 2):150-154.
  • 7[6]Muilenburg DJ,Raymond WW,Wolters PJ,et al. Lys40 but not Arg143 influences selectivity of angiotensin conversion by human alpha-chymase[J]. Biochem Biophys Acta,2002,1596(2):346-356.
  • 8[7]Wei CC,Tian B,Perry G et al. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene[J]. Am J Physiol Heart Circ Physiol,2002,282(6):H2254-H2258.
  • 9[8]Urata H,Boehm KD,Philip A,et al. Cellular localization and regional distribution of an angiotensinⅡ-forming chymase in the heart[J]. J Clin Invest,1993,91:1269-1281.
  • 10[9]Urata H,Healy B,Stewart RW,et al. Angiotensin Ⅱ-forming pathways in normal and failing human hearts[J]. Circ Res,1990,66:883-890.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部